Merck : MRK

All Merck Articles

1096 Articles

Jon C. Ogg | Feb 22, 2019 at 8:52 AM EST

Top Analyst Upgrades and Downgrades: Biogen, Broadcom, Citigroup, Equifax, Fitbit, Intel, Kraft Heinz, Merck, Roku, Under Armour, UTC, Zillow and More

The top analyst upgrades, downgrades and initiations seen on Friday included Biogen, Broadcom, Citigroup, Equifax, Fitbit, Intel, Kraft Heinz, Merck,…

Chris Lange | Feb 21, 2019 at 9:55 AM EST

Is Merck Overpaying for Immune Design?

Immune Design shares absolutely exploded on Thursday after Merck announced that it would be acquiring the firm at what some…

Jon C. Ogg | Feb 20, 2019 at 8:45 AM EST

Top Analyst Upgrades and Downgrades: CenturyLink, Deere, Ecolab, E*Trade, Merck, Southwest Air, S&P, Transocean, Walmart and More

The top analyst upgrades, downgrades and initiations seen on Wednesday included CenturyLink, Deere, Ecolab, E*Trade, Merck, Southwest Airlines, S&P, Transocean…

Chris Lange | Feb 12, 2019 at 9:35 AM EST

Major Pharma Scares Off Short Sellers

The January 31 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Feb 11, 2019 at 7:10 AM EST

The 15 Best Dividend Stocks for Retirees to Own

There are many stocks that are targeted toward mature adults and seniors or that offer classical investing themes for those…

Lee Jackson | Feb 7, 2019 at 7:25 AM EST

Merrill Lynch Adds Top Large Cap Pharmaceutical Leader to US 1 List

A new addition to the Merrill Lynch US 1 list, plus four additional stocks that offer a fair degree of…

Chris Lange | Feb 1, 2019 at 8:35 AM EST

Merck Clears a Low Hurdle for Q4 Earnings

Merck released better-than-expected fourth-quarter financial results after the markets closed on Thursday.

Chris Lange | Jan 31, 2019 at 11:15 AM EST

What to Expect When Merck Reports on Friday

Merck is scheduled to release its fourth-quarter before the markets open on Friday, and analysts are looking for solid top…

Chris Lange | Jan 28, 2019 at 10:10 AM EST

Short Interest Spikes in a Couple Major Pharma Stocks

The January 15 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Jan 27, 2019 at 10:20 AM EST

Apple, Boeing, Microsoft and More Dow Earnings Coming This Week

24/7 Wall St. has put together a preview of those Dow Jones industrials scheduled to report their quarterly results this…

Chris Lange | Jan 24, 2019 at 9:50 AM EST

How the 30 Dow Stocks Are Doing in 2019

24/7 Wall St. has ranked these Dow Stocks on their performance thus far in 2019, as of Wednesday’s closing price.…

Jon C. Ogg | Jan 23, 2019 at 8:50 AM EST

Top Analyst Upgrades and Downgrades: Alphabet, Amazon, Dell, IBM, International Paper, Merck, Pfizer, Tesla, Teva, Walmart and More

The top analyst upgrades, downgrades and initiations seen on Wednesday included Alphabet, Amazon.com, Dell Technologies, IBM, International Paper, Merck, Pfizer,…

Chris Lange | Jan 11, 2019 at 9:50 AM EST

Major Pharma Sees Fading Short Interest

The December 31 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Jan 3, 2019 at 8:45 AM EST

Merck’s Blockbuster Cancer Drug Keytruda Wins Multiple Approvals in Japan

Merck shares were relatively unchanged early on Thursday after the firm announced that its blockbuster drug Keytruda reported a series…

Jon C. Ogg | Jan 2, 2019 at 7:55 AM EST

Bull/Bear Outlook for 2019: How All 30 Dow Stocks Could Take the Market Up to 28,000

See why preliminary 2019 consensus-based forecasting has offered up a likely target of 28,000 on the Dow Jones industrial average…

1 … 18 19 20 21 22 … 74

Merck : MRK

All Merck Articles

Top Analyst Upgrades and Downgrades: Biogen, Broadcom, Citigroup, Equifax, Fitbit, Intel, Kraft Heinz, Merck, Roku, Under Armour, UTC, Zillow and More

Is Merck Overpaying for Immune Design?

Top Analyst Upgrades and Downgrades: CenturyLink, Deere, Ecolab, E*Trade, Merck, Southwest Air, S&P, Transocean, Walmart and More

Major Pharma Scares Off Short Sellers

The 15 Best Dividend Stocks for Retirees to Own

Merrill Lynch Adds Top Large Cap Pharmaceutical Leader to US 1 List

Merck Clears a Low Hurdle for Q4 Earnings

What to Expect When Merck Reports on Friday

Short Interest Spikes in a Couple Major Pharma Stocks

Apple, Boeing, Microsoft and More Dow Earnings Coming This Week

How the 30 Dow Stocks Are Doing in 2019

Top Analyst Upgrades and Downgrades: Alphabet, Amazon, Dell, IBM, International Paper, Merck, Pfizer, Tesla, Teva, Walmart and More

Major Pharma Sees Fading Short Interest

Merck’s Blockbuster Cancer Drug Keytruda Wins Multiple Approvals in Japan

Bull/Bear Outlook for 2019: How All 30 Dow Stocks Could Take the Market Up to 28,000

“The Bottleneck Isn’t the Chips Anymore”: Goldman Sachs Says These Are AI’s Next Big Winners

His $5,000 Employer Disability Check Reduced His Social Security. Six Months Later, It Stopped Counting.

‘You Make $150,000 a Year and You’re Broke, That’s So Weird When You Say That Out Loud’: Ramsey to Caller With $95,000 in Debt

His $5,000 Employer Disability Check Reduced His Social Security. Six Months Later, It Stopped Counting.

'You Make $150,000 a Year and You're Broke, That's So Weird When You Say That Out Loud': Ramsey to Caller With $95,000 in Debt

“The Bottleneck Isn’t the Chips Anymore”: Goldman Sachs Says These Are AI’s Next Big Winners

His $5,000 Employer Disability Check Reduced His Social Security. Six Months Later, It Stopped Counting.

Merck : MRK

All Merck Articles

Top Analyst Upgrades and Downgrades: Biogen, Broadcom, Citigroup, Equifax, Fitbit, Intel, Kraft Heinz, Merck, Roku, Under Armour, UTC, Zillow and More

Is Merck Overpaying for Immune Design?

Top Analyst Upgrades and Downgrades: CenturyLink, Deere, Ecolab, E*Trade, Merck, Southwest Air, S&P, Transocean, Walmart and More

Major Pharma Scares Off Short Sellers

The 15 Best Dividend Stocks for Retirees to Own

Merrill Lynch Adds Top Large Cap Pharmaceutical Leader to US 1 List

Merck Clears a Low Hurdle for Q4 Earnings

What to Expect When Merck Reports on Friday

Short Interest Spikes in a Couple Major Pharma Stocks

Apple, Boeing, Microsoft and More Dow Earnings Coming This Week

How the 30 Dow Stocks Are Doing in 2019

Top Analyst Upgrades and Downgrades: Alphabet, Amazon, Dell, IBM, International Paper, Merck, Pfizer, Tesla, Teva, Walmart and More

Major Pharma Sees Fading Short Interest

Merck’s Blockbuster Cancer Drug Keytruda Wins Multiple Approvals in Japan

Bull/Bear Outlook for 2019: How All 30 Dow Stocks Could Take the Market Up to 28,000

“The Bottleneck Isn’t the Chips Anymore”: Goldman Sachs Says These Are AI’s Next Big Winners

His $5,000 Employer Disability Check Reduced His Social Security. Six Months Later, It Stopped Counting.

‘You Make $150,000 a Year and You’re Broke, That’s So Weird When You Say That Out Loud’: Ramsey to Caller With $95,000 in Debt

Featured Reads

His $5,000 Employer Disability Check Reduced His Social Security. Six Months Later, It Stopped Counting.

'You Make $150,000 a Year and You're Broke, That's So Weird When You Say That Out Loud': Ramsey to Caller With $95,000 in Debt